Document is current
Any future updates will be listed below
-
Authors
Chovatiya, Raj
Ehst, Benjamin
Silverberg, Jonathan
- License Information
-
More Information
Article History
Received: 8 April 2025
Accepted: 16 September 2025
First Online: 23 October 2025
Declarations
:
: Raj Chovatiya has served as an advisor, consultant, speaker, and/or investigator for AbbVie, Acelyrin, Alumis, Amgen, AnaptysBio, Apogee Therapeutics, Arcutis Biotherapeutics Inc., Argenx, Astria Therapeutics Inc., Avalere Health, Beiersdorf, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Castle Biosciences, CLn Skin Care, Dermavant, Eli Lilly and Company, EMD Serono, Formation Bio, Galderma, Genentech, GSK, Incyte, Johnson & Johnson, Kenvue, LEO Pharma, L’Oréal, Nektar Therapeutics, Novartis, Opsidio, Pfizer Inc., RAPT, Regeneron, Sanofi, Sitryx, Takeda, TRex Bio, UCB, and Zai Lab. Raj Chovatiya is an Editorial Board member of Dermatology and Therapy and was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Benjamin Ehst has received fees/honoraria/royalties as an advisory board member, contributor and/or consultant for AbbVie, AnaptysBio, Arcutis Biotherapeutics, Dermavant Sciences, Eli Lilly, Evelo Biosciences, Evommune, Janssen Biotech, LEO Pharma, Novartis, Ortho Dermatologics, Proivant, Up-To-Date and UCB; received speaking fees from AbbVie, Dermavant Sciences, Eli Lilly, Incyte, LEO Pharma, Novartis, National Psoriasis Foundation, Regeneron, Ortho Dermatologics, Sanofi-Genzyme and UCB; received institutional funding as an investigator for AbbVie, Aclaris Therapeutics, Allakos, Almirall, Alumis, Amgen, AnaptysBio, Apogee Therapeutics, Arcutis Biotherapeutics, BMS, Celgene, Concert Pharmaceuticals, Dermavant Sciences, Eli Lilly, Evelo Biosciences, Incyte, Janssen Biotech, Kymab, LEO Pharma A/S, Novan Inc., Novartis, Pfizer, Regeneron, Sanofi-Genzyme, Sun Pharma, Takeda, UCB, and Ventyx Biosciences. Jonathan Silverberg reports honoraria as a consultant/advisory board member from LEO Pharma and has acted as a consultant for and/or received grants/honoraria from AbbVie, AnaptysBio, Asana Biosciences, Galderma Research and Development, GSK, Glenmark, Kiniksa, LEO Pharma, Lilly, MedImmune, Menlo Therapeutics, Pfizer, PuriCore, Regeneron, and Sanofi.
: This article does not contain any studies with human participants or animals performed by any of the authors.
